Clinical Trial Update: Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 study of belotecan (Camtobell Inj) given on a weekly schedule in patients with non-small cell lung cancer who were previously treated with chemotherap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Camtobell Inj (Belotecan)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED